June 9 (Reuters) - Synaptogenix Inc SNPX.O:
SYNAPTOGENIX INC: ON JUNE 8, ALAN J. TUCHMAN RESIGNED AS CEO AND DIRECTOR OF CO
SYNAPTOGENIX INC: TUCHMAN TO SERVE AS CHIEF MEDICAL OFFICER OF CO
SYNAPTOGENIX INC: ON JUNE 6, JOSHUA SILVERMAN APPOINTED AS EXECUTIVE CHAIRMAN OF CO’S BOARD OF DIRECTORS
Source text: [ID:n0001104659-25-057640]
Further company coverage: SNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.